UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

Annals of oncology, 2018-10, Vol.29, p.viii709-viii709

2018

Volltextzugriff (PDF)

A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Annals of oncology, 2016-10, Vol.27, p.vi98-vi98

2016

Volltextzugriff (PDF)

Abstract GS3-08: Alpelisib + fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS3-08-GS3-08

2019

Volltextzugriff (PDF)

LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Abstract OT2-01-04: SOLAR-1: A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.OT2-01-04-OT2-01-04

2017

Volltextzugriff (PDF)

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Annals of oncology, 2016-12, Vol.27, p.ix41-ix41

2016

Volltextzugriff (PDF)

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

Presence of Zinc and Calcium Permeant Channels in the Inner Membrane of the Nuclear Envelope

Biochemical and biophysical research communications, 1997-06, Vol.235 (1), p.236-241

1997

Volltextzugriff (PDF)

Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316)

Journal of thrombosis and haemostasis, 2011-10, Vol.9 (10), p.2100-2102

2011

Volltextzugriff (PDF)

Extreme Events in Finance: A Handbook of Extreme Value Theory and Its Applications

Longin, Francois

1, 2016

Volltextzugriff (PDF)

Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study

Multiple sclerosis and related disorders, 2018-10, Vol.25, p.276-281

2018

Volltextzugriff (PDF)

PND10 - Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

Value in health, 2016-11, Vol.19 (7), p.A426-A427

2016

Volltextzugriff (PDF)

Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

Value in health, 2016-11, Vol.19 (7), p.A426-A427

2016

Volltextzugriff (PDF)

RelSEP : description des prises en charge en vie réelle dans une cohorte de patients atteints de sclérose en plaques et suivis dans un registre épidémiologique en région Lorraine

Revue d'épidémiologie et de santé publique, 2016-10, Vol.64, p.S269-S270

2016

Volltextzugriff (PDF)

Effects of Valproic Acid, Carbamazepine, and Phenobarbitone on the Fatty Acid Composition of Erythrocyte Membranes in Children

Epilepsia (Copenhagen), 2003-05, Vol.44 (5), p.708-711

2003

Volltextzugriff (PDF)

Bootstrap Methods in Statistics of Extremes

Extreme Events in Finance, 2016, p.117-138

2016

Volltextzugriff (PDF)

Estimation Methods for Value at Risk

Extreme Events in Finance, 2016, p.283-356

2016

Volltextzugriff (PDF)

Extreme Value Theory: An Introductory Overview

Extreme Events in Finance, 2016, p.53-95

2016

Volltextzugriff (PDF)

Statistics of Extremes: Challenges and Opportunities

Extreme Events in Finance, 2016

Longin, Francois

2016

Volltextzugriff (PDF)

The Extreme Value Problem in Finance: Comparing the Pragmatic Program with the Mandelbrot Program

Extreme Events in Finance, 2016 (1), p.25-51

2016

Volltextzugriff (PDF)

Estimation of the Extreme Value Index

Extreme Events in Finance, 2016, p.97-115

2016

Volltextzugriff (PDF)

Extreme Values Statistics for Markov Chains with Applications to Finance and Insurance

Extreme Events in Finance, 2016, p.139-170

2016

Volltextzugriff (PDF)

The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania

AIDS (London), 1992-12, Vol.6 (12), p.1521-1528

1992

Volltextzugriff (PDF)

Managing Operational Risk in the Banking Business-An Internal Auditor Point of View

Extreme Events in Finance, 2016, p.555-562

2016

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(52)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Abstract GS3-08: Alpelisib + fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial

LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

Abstract OT2-01-04: SOLAR-1: A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Presence of Zinc and Calcium Permeant Channels in the Inner Membrane of the Nuclear Envelope

Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316)

Extreme Events in Finance: A Handbook of Extreme Value Theory and Its Applications

Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study

PND10 - Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

RelSEP : description des prises en charge en vie réelle dans une cohorte de patients atteints de sclérose en plaques et suivis dans un registre épidémiologique en région Lorraine

Effects of Valproic Acid, Carbamazepine, and Phenobarbitone on the Fatty Acid Composition of Erythrocyte Membranes in Children

“Artificial intelligence”: Which services, which applications, which results and which development today in clinical research? Which impact on the quality of care? Which recommendations?

Bootstrap Methods in Statistics of Extremes

Estimation Methods for Value at Risk

Extreme Value Theory: An Introductory Overview

Statistics of Extremes: Challenges and Opportunities

The Extreme Value Problem in Finance: Comparing the Pragmatic Program with the Mandelbrot Program

Estimation of the Extreme Value Index

Extreme Values Statistics for Markov Chains with Applications to Finance and Insurance

The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania

Managing Operational Risk in the Banking Business-An Internal Auditor Point of View

Suchergebnisse filtern